Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

Joshua Aviram

doi:10.1007/s00213-025-06883-y

Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

Joshua Aviram

Department of Nursing

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	225-228
Number of pages	4
Journal	Psychopharmacology
Volume	243
Issue number	1
DOIs	https://doi.org/10.1007/s00213-025-06883-y
State	Published - 15 Aug 2025

Access to Document

10.1007/s00213-025-06883-y

Cite this

@article{e7fd9f40db59484fa2b9934b68c0de23,

title = "Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting",

author = "Joshua Aviram",

year = "2025",

month = aug,

day = "15",

doi = "10.1007/s00213-025-06883-y",

language = "אנגלית",

volume = "243",

pages = "225--228",

journal = "Psychopharmacology",

issn = "0033-3158",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Response to Barner et al. (2025) on comment on Zabik et al. (2024)

T2 - special considerations for cannabis research in RCTs and feasibility in a clinical setting

AU - Aviram, Joshua

PY - 2025/8/15

Y1 - 2025/8/15

UR - https://www.scopus.com/pages/publications/105013473585

U2 - 10.1007/s00213-025-06883-y

DO - 10.1007/s00213-025-06883-y

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 40815407

AN - SCOPUS:105013473585

SN - 0033-3158

VL - 243

SP - 225

EP - 228

JO - Psychopharmacology

JF - Psychopharmacology

IS - 1

ER -

Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

Access to Document

Other files and links

Cite this